CoreAge Rx and IVY RX advertise home NAD+ injection services, but their public price descriptions are not identical. IVY’s page now says “From $179 (use varies),” which should not be silently converted into a fixed monthly supply.
CoreAge has featured commercial placement on this site. This comparison examines price wording and quality representations rather than declaring that either company provides better clinical results.
IVY’s $179 starting figure is qualified by use varies. Align supply periods and verify the actual pharmacy before drawing a price or quality conclusion.
Compare supply periods before price differences
CoreAge publishes a monthly offer, while IVY’s current starting-price label includes a use-varies qualifier. Ask IVY what the selected amount supplies and when another charge would occur. Ask CoreAge which public offer applies to the actual prescription.
A dollar difference is meaningful only after the quantity, allowed use period, and included services are aligned. The IVY review and CoreAge review preserve those distinctions.
IVY provides specific testing descriptions
IVY describes potency and sterility testing and refers to registered pharmacies or laboratories. These details can support specific questions about the actual preparation. We have not reviewed a patient’s batch documentation or independently audited those representations.
Ask which pharmacy will dispense the medication, which tests apply to that lot, and how a quality concern is investigated. A graphic saying a test passed is different from a report identifying the product you receive.
Registration and drug approval are separate
FDA registration of a facility does not mean a compounded NAD prescription has received FDA approval. The same distinction applies to any quality language used by CoreAge. Professional licensing, facility registration, analytical testing, and demonstrated clinical effectiveness each answer a different question.
Our compounded-NAD safety guide explains why sterility and endotoxin questions cannot be replaced by a general purity or potency claim.
Ask how support works beyond delivery
Both a medication shipment and a convenient app can be useful, but neither measures access to clinical advice. Ask who handles medical questions, when review is available, and how you would obtain help for a problem that cannot wait for the next refill.
Also distinguish pharmacy questions from billing questions. A patient should know where to ask about an unclear label, a delayed package, and a recurring charge before the first order is processed.
The decision depends on the missing details
IVY may be useful to investigate if you want to question its published testing process in detail. CoreAge may be useful to investigate if its selected monthly offer fits your budget and care needs. Neither rationale establishes superior efficacy.
Get comparable written offers and a clear pharmacy assignment. If one provider cannot explain the supply period or clinical follow-up, the unexplained detail matters more than a headline price advantage.
Sources & reading notes
Editorial source review updated September 19, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- CoreAge Rx: current NAD+ offer Provider advertising; offer page displays $99/month. Checked September 19, 2026.
- CoreAge Rx: NAD+ Injectable product page Provider advertising; product page displays a different starting price of $93/month.
- IVY RX: NAD+ Injection Provider lists a starting price of $179 with use-varies wording and describes its testing process. Supply period requires confirmation.
- FDA: ingredients suitable for sterile compounding Safety notice describing reported reactions and ingredient-quality concerns.
- FDA: compounding questions and answers Explains that compounded drugs are not FDA-approved.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.